Prostate Cancer - Results from #19940

High dose versus conventional dose in external beam radiotherapy of prostate cancer: A meta-analysis of long-term follow-up - Abstract October 14, 2014

External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer - Abstract October 14, 2014

Loose versus stranded seeds in permanent prostate brachytherapy: Dosimetric comparison of intraoperative plans - Abstract October 13, 2014

Salvage treatments following prostate radiation therapy: Role of the urologist - Abstract October 13, 2014

Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer - Abstract October 11, 2014

The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy - Abstract October 11, 2014

Clinical outcome of patients with lymph node-positive prostate cancer following radical prostatectomy and extended sentinel lymph node dissection - Abstract October 11, 2014

A global quality assurance system for personalized radiation therapy treatment planning for the prostate (or other sites) - Abstract October 11, 2014

Modifier 22 on perioperative outcomes of robotic assisted laparoscopic prostatectomy - Abstract October 11, 2014

Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial - Abstract October 11, 2014

How I do it: Managing bone health in patients with prostate cancer - Abstract October 10, 2014

Perspectives on the clinical management of localized prostate cancer - Full Text Article October 9, 2014

The role of mRNA splicing in prostate cancer - Full Text Article October 9, 2014

Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cance - Abstract October 9, 2014

Ureteral metastasis from prostate cancer - Abstract October 9, 2014

Oncologic outcomes of cryosurgery as primary treatment in T3 prostate cancer: Experience of a single center - Abstract October 9, 2014

Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy - Abstract October 9, 2014

Urinary diversions after radiation for prostate cancer: Indications and treatment - Abstract October 9, 2014

The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men - Abstract October 9, 2014

Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies - Abstract October 9, 2014

Page 998 of 1455